Alkaloid AD Skopje (XMAE:ALK) Shares Outstanding (EOP): 1 Mil (As of Mar. 2026)


XMAE:ALK Alkaloid AD Skopje XMAE:ALK
88 GF Score
Price MKD23,500.00
GF Value MKD27,223.26
Valuation Modestly Undervalued
View Full Analysis

What is Alkaloid AD Skopje Shares Outstanding (EOP)?

Alkaloid AD Skopje XMAE:ALK -2.91% 88 Shares Outstanding (EOP) is 1 Mil as of Mar. 2026. GuruFocus rates XMAE:ALK with a GF Score™ of 88/100 and a GF Value™ of MKD27,223.26 (Modestly Undervalued).

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Alkaloid AD Skopje's shares outstanding for the quarter that ended in Mar. 2026 was 1 Mil.

Alkaloid AD Skopje's quarterly shares outstanding stayed the same from Dec. 2025 (1 Mil) to Mar. 2026 (1 Mil).

Alkaloid AD Skopje's annual shares outstanding stayed the same from Dec. 2024 (1 Mil) to Dec. 2025 (1 Mil).


Alkaloid AD Skopje  (XMAE:ALK) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Alkaloid AD Skopje Shares Outstanding (EOP) Related Terms


Alkaloid AD Skopje Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Alkaloid AD Skopje's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkaloid AD Skopje Shares Outstanding (EOP) Chart

Alkaloid AD Skopje Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.41 1.41 1.41 1.41 1.41

Alkaloid AD Skopje Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 1.41 1.41 1.41 1.41

XMAE:ALK vs ZTS, UTHR, VTRS: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkaloid AD Skopje Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Alkaloid AD Skopje's Shares Outstanding (EOP) falls into.


XMAE:ALK
88GF Score
Alkaloid AD Skopje XMAE:ALK
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkaloid AD Skopje Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 1 Mil mean?
Alkaloid AD Skopje (XMAE:ALK) has a Shares Outstanding (EOP) of 1 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Alkaloid AD Skopje and its competitors.
Is Alkaloid AD Skopje's Shares Outstanding (EOP) too high?
Alkaloid AD Skopje's current Shares Outstanding (EOP) is 1 Mil. Overall, Alkaloid AD Skopje has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkaloid AD Skopje's Shares Outstanding (EOP) compare to ZTS and UTHR?
Alkaloid AD Skopje's Shares Outstanding (EOP) of 1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Alkaloid AD Skopje and its competitors. Alkaloid AD Skopje's current Shares Outstanding (EOP) is 1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkaloid AD Skopje stock overvalued right now?
Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,223.26, compared to a current price of MKD23,500.00 — trading 13.7% below its estimated fair value. The current Shares Outstanding (EOP) is 1 Mil. Alkaloid AD Skopje's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current Shares Outstanding (EOP) is 1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?

Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued. The current stock price of MKD23,500.00 is trading 13.7% below its estimated GF Value™ of MKD27,223.26. GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.

Key valuation signals for XMAE:ALK:

  • Shares Outstanding (EOP): 1 Mil
  • GF Value™: MKD27,223.26 vs. price of MKD23,500.00 (13.7% below fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alkaloid AD Skopje Business Description

Address Boulevard Aleksandar, Makedonski 12, Skopje, MKD, 1000
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
88GF Score

Get the complete analysis for XMAE:ALK

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MKD23,500.00
Price
MKD27,223.26
GF Value